VJHemOnc is committed to improving our service to you

MDS 2020 | Clonal hematopoiesis in the cancer setting

VJHemOnc is committed to improving our service to you

Rafael Bejar

Rafael Bejar, MD, PhD, UC San Diego Moores Cancer Center, San Diego, CA, discusses the clinical implications of clonal hematopoiesis in the cancer setting. Specifically, he focuses on therapy-related myeloid neoplasms and potential strategies to counter clonal expansion. This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter